The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cell separation technologies market was valued at US$ 7.62 Billion in 2021.
We expect the global cell separation technologies market to exhibit a CAGR of 16.10% during 2022-
The growing utilization of cell separation technologies to treat various chronic diseases, such as
cancer, AIDS, cystic fibrosis, etc., and to enhance drug discovery procedures, is primarily driving the
global cell separation technologies market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of cell separation
technologies for developing novel vaccines, drugs, and testing kits to combat the risk of the
Based on the product, the global cell separation technologies market has been segmented into
instruments and consumables. Currently, consumables represent the largest market share.
Based on the end user, the global cell separation technologies market can be bifurcated into
research laboratories and institute, biotechnology and biopharmaceutical companies, and cell banks.
Among these, the biotechnology and biopharmaceutical companies currently account for the
majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global cell separation technologies market include Akadeum Life
Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning
Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG
(haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation, and Thermo Fisher
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at